Colorectal cancer (CRC) is a complex and widespread disease, currently ranked as
the third most frequent cancer worldwide. It is well known that the gut
microbiota has an essential role in the initiation and promotion of different
cancer types, particularly gastrointestinal tumors. In fact, bacteria can
trigger chronic inflammation of the gastric mucosal, which can induce
irreversible changes to intestinal epithelial cells, thus predisposing
individuals to cancer. Some bacterial strains, such as Helicobacter
pylori, Streptococcus bovis, Bacteroides fragilis, Clostridium
septicum and Fusobacterium spp. have a well
established role in CRC development. However, the role of Enterococcus
faecalis still remains controversial. While part of the literature
suggests a harmful role, other papers reported E. faecalis as
an important probiotic microorganism, with great applicability in food products.
In this review we have examined the vast majority of published data about
E. faecalis either in CRC development or concerning its
protective role. Our analysis should provide some answers regarding the
controversial role of E. faecalis in CRC.